IPO Alert: Silverback Therapeutics

Silverback Therapeutics Inc., a clinical-stage biopharmaceutical company developing systemically delivered, tissue targeted therapeutics for the treatment of cancer and other chronic viral infections, is scheduled to hit the Nasdaq Global Select Market on December 4, under the symbol "SBTX".